1.
Unsuccessful trial accrual and human subjects protections: An empirical analysis of recently closed trials
by Carlisle, Benjamin
Clinical trials (London, England), 2015-02, Vol.12 (1), p.77-83
2.
Ethical development of stem-cell-based interventions
by MacPherson, Amanda
Nature medicine, 2019-07, Vol.25 (7), p.1037-1044
3.
Are outcome-adaptive allocation trials ethical?
by Hey, Spencer Phillips
Clinical trials (London, England), 2015-04, Vol.12 (2), p.102-106
4.
Individualized therapy trials: navigating patient care, research goals and ethics
by Kane, Patrick Bodilly
Nature medicine, 2021-10-01, Vol.27 (10), p.1679-1686
5.
Should preclinical studies be registered?
by Kimmelman, Jonathan
Nature biotechnology, 2012-06-07, Vol.30 (6), p.488-489
6.
The social function of clinical equipoise
by Kimmelman, Jonathan
Clinical trials (London, England), 2012-10, Vol.9 (5), p.630-631
7.
Assessing risk/benefit for trials using preclinical evidence: a proposal
by Kimmelman, Jonathan
Journal of medical ethics, 2016-01, Vol.42 (1), p.50-53
8.
New ISSCR guidelines: clinical translation of stem cell research
by Kimmelman, Jonathan
The Lancet (British edition), 2016, Vol.387 (10032), p.1979-1981
9.
Justice in translation: from bench to bedside in the developing world
by London, Alex John, PhD
The Lancet (British edition), 2008, Vol.372 (9632), p.82-85
10.
Elements of informed consent and decision quality were poorly correlated in informed consent documents
by Brehaut, Jamie C
Journal of clinical epidemiology, 2015, Vol.68 (12), p.1472-1480
11.
Helsinki discords: FDA, ethics, and international drug trials
by Kimmelman, Jonathan
The Lancet (British edition), 2009, Vol.373 (9657), p.13-14
12.
Informed consent documents do not encourage good-quality decision making
by Brehaut, Jamie C
Journal of clinical epidemiology, 2012, Vol.65 (7), p.708-724
13.
A guide to the perplexed: how to navigate conflicting research ethics policies
by Kimmelman, Jonathan
Health law review, 2011-06-22, Vol.19 (3), p.56
14.
The promise and perils of criminal DNA databanking
by Kimmelman, Jonathan
Nature biotechnology, 2000-07, Vol.18 (7), p.695-696
15.
Rejoinder
by Hey, Spencer Phillips
Clinical trials (London, England), 2015-04, Vol.12 (2), p.125-127
16.
Rejoinder
by Hey, Spencer Phillips
Clinical trials (London, England), 2015-04, Vol.12 (2), p.125-127
17.
Rejoinder
by Spencer Phillips Hey
Clinical trials (London, England), 2015-04-01, Vol.12 (2), p.125
18.
Rejoinder
by Hey, Spencer Phillips
Clinical trials (London, England), 2015-04, Vol.12 (2), p.125
19.
Rejoinder
by Hey, Spencer Phillips
Clinical trials (London, England), 2015-04-01, Vol.12 (2), p.125-127
20.
Medical Research, Risk, and Bystanders
by Kimmelman, Jonathan
IRB, 2005-07-01, Vol.27 (4), p.1-6
